AU2014254016B2 - Peptide compounds and methods of production and use thereof - Google Patents
Peptide compounds and methods of production and use thereof Download PDFInfo
- Publication number
- AU2014254016B2 AU2014254016B2 AU2014254016A AU2014254016A AU2014254016B2 AU 2014254016 B2 AU2014254016 B2 AU 2014254016B2 AU 2014254016 A AU2014254016 A AU 2014254016A AU 2014254016 A AU2014254016 A AU 2014254016A AU 2014254016 B2 AU2014254016 B2 AU 2014254016B2
- Authority
- AU
- Australia
- Prior art keywords
- arg
- ala
- gly
- phe
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361812584P | 2013-04-16 | 2013-04-16 | |
| US61/812,584 | 2013-04-16 | ||
| US201361813527P | 2013-04-18 | 2013-04-18 | |
| US61/813,527 | 2013-04-18 | ||
| AUPCT/US2013/072884 | 2013-12-03 | ||
| PCT/US2013/072884 WO2014089088A1 (en) | 2012-12-03 | 2013-12-03 | Peptide compounds and methods of production and use thereof |
| PCT/US2014/034392 WO2014172474A2 (en) | 2013-04-16 | 2014-04-16 | Peptide compounds and methods of production and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014254016A1 AU2014254016A1 (en) | 2015-11-05 |
| AU2014254016B2 true AU2014254016B2 (en) | 2018-02-22 |
Family
ID=51731978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014254016A Active AU2014254016B2 (en) | 2013-04-16 | 2014-04-16 | Peptide compounds and methods of production and use thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9624283B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2986309B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6405365B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014254016B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2908693C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2986309T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014172474A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3802568A4 (en) | 2018-06-08 | 2022-07-13 | The Board of Regents of the University of Oklahoma | PEPTIDE THERAPEUTICS USED TO TREAT ALZHEIMER'S DISEASE AND RELATED DISEASES |
| JP2025016812A (ja) * | 2021-12-16 | 2025-02-05 | レグセル株式会社 | 免疫系の異常に関連する疾患、障害または症状を処置するための医薬組成物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070135341A1 (en) * | 2005-08-01 | 2007-06-14 | Pereira H A | Antifungal peptides and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484885A (en) * | 1989-07-05 | 1996-01-16 | Emory University | Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37 |
| US5627262A (en) | 1989-07-05 | 1997-05-06 | The Board Of Regents Of The University Of Oklahoma | Method and composition for the treatment of septic shock |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US6107460A (en) * | 1999-03-01 | 2000-08-22 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use thereof |
| US8450071B2 (en) | 2002-03-08 | 2013-05-28 | The Board Of Regents Of The University Of Oklahoma | Biomarker and method for detecting a chronic inflammatory-associated disease |
| AU2003220034A1 (en) | 2002-03-08 | 2003-09-22 | Heloise, Anne, Pereira, Ph. D. | An early detection marker for chronic inflammatory associated diseases |
| US7655480B2 (en) | 2002-03-08 | 2010-02-02 | The Board Of Regents Of The University Of Oklahoma | Method for predicting sepsis or an acute infectious inflammatory response |
| US7354900B2 (en) * | 2002-05-03 | 2008-04-08 | The Board Of Regents Of The University Of Oklahoma | Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides |
| CN101027318B (zh) | 2004-07-19 | 2016-05-25 | 比奥孔有限公司 | 胰岛素-低聚物共轭物,制剂及其用途 |
| US9399675B2 (en) | 2007-02-28 | 2016-07-26 | The Board Of Regents Of The University Of Oklahoma | Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration |
| GB0817121D0 (en) * | 2008-09-18 | 2008-10-29 | Univ St Andrews | Anti-fungal therapy |
| WO2011103567A2 (en) | 2010-02-22 | 2011-08-25 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Peptides and methods for inducing cell death |
| CA2797033C (en) | 2010-04-22 | 2021-10-19 | Longevity Biotech, Inc. | Highly active polypeptides and methods of making and using the same |
| US9096679B2 (en) | 2012-12-03 | 2015-08-04 | The Board Of Regents Of The University Of Oklahoma | Peptide compounds and methods of production and use thereof |
| US9603896B2 (en) | 2012-12-03 | 2017-03-28 | The Board Of Regents Of The University Of Oklahoma | Peptide compounds and methods of production and use thereof |
-
2014
- 2014-04-16 JP JP2016509072A patent/JP6405365B2/ja active Active
- 2014-04-16 AU AU2014254016A patent/AU2014254016B2/en active Active
- 2014-04-16 US US14/781,801 patent/US9624283B2/en active Active
- 2014-04-16 CA CA2908693A patent/CA2908693C/en active Active
- 2014-04-16 EP EP14784977.2A patent/EP2986309B1/en active Active
- 2014-04-16 WO PCT/US2014/034392 patent/WO2014172474A2/en not_active Ceased
- 2014-04-16 DK DK14784977.2T patent/DK2986309T3/en active
-
2016
- 2016-11-29 US US15/363,670 patent/US20170073385A1/en not_active Abandoned
-
2018
- 2018-03-15 US US15/922,246 patent/US20180208633A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070135341A1 (en) * | 2005-08-01 | 2007-06-14 | Pereira H A | Antifungal peptides and methods of use thereof |
Non-Patent Citations (4)
| Title |
|---|
| BACH A. et al., PNAS., 2012, vol. 109, no. 9, pages 3317 - 3322 * |
| GAULT V. A. et al., BIOCHEMICAL PHARMACOLOGY, 2008, vol. 75, no. 12, pages 2325 - 2333 * |
| KATO A. et al., BIOPOLYMERS, 2007, vol. 85, no. 1, pages 12 - 18 * |
| PEREIRA H. A.,CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, vol. 7, no. 4, pages 229 - 234 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014172474A2 (en) | 2014-10-23 |
| CA2908693A1 (en) | 2014-10-23 |
| JP6405365B2 (ja) | 2018-10-17 |
| DK2986309T3 (en) | 2018-05-07 |
| US9624283B2 (en) | 2017-04-18 |
| EP2986309A4 (en) | 2017-03-08 |
| AU2014254016A1 (en) | 2015-11-05 |
| JP2016519109A (ja) | 2016-06-30 |
| EP2986309B1 (en) | 2018-02-14 |
| US20170073385A1 (en) | 2017-03-16 |
| EP2986309A2 (en) | 2016-02-24 |
| US20180208633A1 (en) | 2018-07-26 |
| CA2908693C (en) | 2021-04-06 |
| US20160060315A1 (en) | 2016-03-03 |
| WO2014172474A3 (en) | 2015-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20160317617A1 (en) | Peptide Compounds and Methods of Production and Use Thereof | |
| US9862748B2 (en) | Peptide compounds and methods of production and use thereof | |
| EP3233902B1 (en) | Antifibrotic activity of gas6 inhibitor | |
| WO2021237239A1 (en) | Active low molecular weight variant of angiotensin converting enzyme 2 (ace2) for the treatment of diseases and conditions of the eye | |
| JP2012512170A (ja) | 血管バリア機能の促進および肺線維症の治療する組成物および方法 | |
| US20180208633A1 (en) | Peptide Compounds and Methods of Production and Use Thereof | |
| JP2016501889A5 (cg-RX-API-DMAC7.html) | ||
| WO2010137594A1 (ja) | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 | |
| JPWO2010061915A1 (ja) | 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途 | |
| US11884710B2 (en) | Peptide compounds and methods of use in wound healing | |
| JP6042106B2 (ja) | メチオニン・スルホキシドを含む新規ポリペプチド | |
| AU2006275417B2 (en) | Antifungal peptides and methods of use thereof | |
| JP2025503607A (ja) | セルピンペプチドおよびその使用方法 | |
| KR20250170772A (ko) | 이중 알라민 수용체 특이적 표적 펩티드를 포함하는 패혈증 치료용 약학 조성물 | |
| HK1244825B (en) | Antifibrotic activity of gas6 inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |